Veracyte (VCYT) Operating Leases (2019 - 2026)

Veracyte has reported Operating Leases for 8 years, with the latest figure at $40.1 million in Q2 2026.

• Operating Leases for Q2 2026 came in at $40.1 million, down 20.81% year-over-year; the trailing twelve-month figure through Jun 2026 was $40.1 million (down 20.81% YoY), and the FY2025 annual result was $35.6 million, down 17.66% from the prior year.
• Operating Leases grew to $40.1 million in Q2 2026, from $39.3 million in the prior quarter.
• Over five years, Operating Leases peaked at $50.6 million in Q2 2025 and troughed at $7.5 million in Q4 2023.
• A 5-year average of $25.8 million and a median of $18.5 million in 2022 frame the typical range for Operating Leases.
• The widest annual swing landed in 2023, when Operating Leases fell 29.33%; it then surged 474.58% in 2024.
• A 5-year view of Operating Leases shows it stood at $10.6 million in 2022, then fell by 29.33% to $7.5 million in 2023, then surged by 474.58% to $43.2 million in 2024, then decreased by 17.66% to $35.6 million in 2025, then rose by 12.65% to $40.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $40.1 million in Q2 2026, $39.3 million in Q1 2026, and $35.6 million in Q4 2025.